知镜 Cognispect · 医学文献与研究工作台

Secondary Hypertension

Regalla DKR, Hegde S, Ahmed I.
· 2026-09-14 · PMID 31335025

文献摘要

Hypertension is the single most important modifiable risk factor for cardiovascular disease, chronic kidney disease, and premature death. According to the Noncommunicable Diseases Risk Factor Collaboration, results from a pooled analysis of 1201 population-representative studies encompassing 104 million participants showed that the global number of adults aged 30 to 79 years with hypertension doubled from 650 million in 1990 to 1.28 billion in 2019, with substantial geographic variation in treatment and control rates. Blood pressure control remains a major challenge for global health systems, with fewer than 1 in 5 adults with hypertension achieving adequate blood pressure control worldwide. While essential (primary) hypertension accounts for most cases, secondary hypertension, defined as elevated blood pressure attributable to a specific, identifiable cause, represents a clinically significant subset that requires targeted evaluation and treatment. The prevalence of secondary hypertension has historically been estimated at 5% to 10% of all adults with hypertension. However, results from contemporary studies using systematic screening protocols suggested that the true prevalence may be considerably higher, with estimates ranging from 10% to 35% of all hypertensive adults. Results from a 2024 study published in Hypertension that evaluated 2090 young adults (aged 18 to 40 years) with confirmed hypertension identified secondary causes in 29.6% of patients. Similarly, expanded screening for primary aldosteronism has revealed prevalence rates of 5% to 20% depending on the clinical setting. The importance of detecting secondary hypertension lies in its therapeutic implications: identification and correction of the underlying cause can lead to cure of hypertension or substantial improvement in blood pressure control, thereby reducing cardiovascular events, end-organ damage, and the burden of lifelong antihypertensive therapy. The 2024 European Society of Cardiology (ESC) Guidelines and the 2025 American College of Cardiology (ACC) and American Heart Association (AHA) Guidelines both emphasize the importance of screening for secondary causes in selected populations, particularly young adults younger than 40 years and patients with resistant hypertension. Clinicians treating patients with hypertension should recognize clinical clues suggesting a secondary cause. Current guidelines recommend investigation for secondary hypertension in the following clinical scenarios: Resistant hypertension: Blood pressure persistently greater than or equal to goal (130/80 mm Hg per 2025 ACC/AHA guidelines; 140/90 mm Hg per 2024 ESC guidelines) despite confirmed adherence to maximally tolerated doses of at least 3 antihypertensive agents from different classes, including a diuretic. Acute rise in blood pressure: New or abrupt worsening of hypertension in a patient with previously stable blood pressure control. Early-onset hypertension: Hypertension diagnosed before age 30, per the 2025 ACC/AHA guidelines, in the absence of traditional risk factors (eg, obesity or family history), particularly in Black individuals. The 2024 ESC Guidelines apply a broader cutoff, recommending comprehensive secondary-cause screening in all adults younger than 40 years, regardless of other risk factors. Severe or malignant hypertension: Blood pressure greater than 180/110 mm Hg with evidence of end-organ damage (acute kidney injury, hypertensive retinopathy, left ventricular hypertrophy, flash pulmonary edema, or neurological manifestations). Electrolyte abnormalities: Hypertension accompanied by spontaneous or diuretic-induced hypokalemia or metabolic alkalosis, suggesting mineralocorticoid excess. Prepubertal hypertension: Hypertension diagnosed before puberty warrants thorough evaluation for secondary causes because 70% to 85% of hypertension in children younger than 12 years is secondary. Abnormal ambulatory blood pressure patterns: Nondipping or reverse dipping on 24-hour ambulatory blood pressure monitoring may suggest a secondary cause of hypertension.

在知镜精读原文来源

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。